Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Essential Role for Telomeric Repeat-Binding Factor 2 in Cardiac Development and Function.

Created on 06 Jul 2026

Authors

Ali Hakim Shoushtari, Aysenure Danis, Michael Wayne Stoner, Jeffrey Baust, Andrea Sebastiani, Paramesha Bugga, Janet R Manning, Bellina A S Mushala, Nisha Bhattarai, Imad Al Ghouleh, Iain Scott, Maryam Sharifi-Sanjani

Published in

FASEB bioAdvances. Volume 8. Issue 7. Pages e70133. Epub Jul 03, 2026.

Abstract

Telomere repeat-binding factor 2 (Trf2) is essential for protecting our telomeres. While Trf2 global deletion is lethal, its role in organ-specific development, particularly in the heart, remains less understood. In this study, we investigated the role of Trf2 in cardiac development and function. Our studies reveal that cardiomyocyte (CM)-specific loss of Trf2 leads to profound defects in heart morphology, including impaired ventricular wall formation and compromised CM proliferation, concurrent with no CM telomere length attrition. Further, in vivo functional assessment and molecular analyses of CM-Trf2 deficient ventricles revealed severe cardiac dysfunction and, interestingly, altered nuclear envelope gene expression. Our work provides new insights into the essential role of Trf2 in heart development and function and potential avenues for therapeutic intervention targeting telomere biology.

PMID:
42405350
Bibliographic data and abstract were imported from PubMed on 06 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement